Urinary levels of IQGAP3 showed good utility as a diagnostic marker that candifferentiate between BC patients and non-cancer patients with hematuria(PicoGreen-adjusted AUC, 0.910; sensitivity, 80.0%; specificity, 90.7%;RiboGreen-adjusted AUC, 0.854; sensitivity, 92.2%; specificity, 65.2%)(Figure 5). This evidence concerns the gene IQGAP3 and breast cancer.